Research programme: cysteine proteinase inhibitors - NAEJA
Alternative Names: Cysteine protease inhibitors research programme - NAEJA; Cysteine proteinase inhibitors research programme - NAEJA; Research programme: cysteine protease inhibitors - NAEJA; SYN 2019; SYN 2448Latest Information Update: 25 Oct 2007
At a glance
- Originator NAEJA Pharmaceutical
- Class
- Mechanism of Action Cysteine endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Periodontal disorders; Postmenopausal osteoporosis; Rheumatoid arthritis
Most Recent Events
- 25 Oct 2006 Discontinued - Preclinical for Asthma in Canada (PO)
- 25 Oct 2006 Discontinued - Preclinical for Periodontal disorders in Canada (PO)
- 25 Oct 2006 Discontinued - Preclinical for Postmenopausal osteoporosis in Canada (PO)